Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECG-Lihir: Safety of Monthly DHA/PPQ for Malaria
NCT02605720Phase 3Completed
- Sponsor
- Lihir Medical Centre
- Start
- Sep 2015
- Primary completion
- Jan 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin in malaria, sponsored by Lihir Medical Centre. Started Sep 2015; status: completed.
02
Drugs
dihydroartemisinin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02605720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605720.